Mid-Day Breakouts Report - Thursday, December 14th, 2017

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, October 20, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - THURSDAY, DECEMBER 14TH, 2017
Previous Mid Day Report Next Mid Day Report >>>

DOW 24615.54 30.11 (0.12%) | NASDAQ 6890.64 14.84 (0.22%) | S&P 500 2664.41 1.56 (0.06%)

Time of Screening : 12/14/2017 12:08:15 PM Report Released : 12/14/2017 12:36:20 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 65% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
BABA - NYSE - INTERNET - Internet Software & Services Alibaba Group Holding Limited	$171.82	-4.65 -2.64%	$173.39	$191.75	-10.39%	20,142,063 106.79%	18,861,000
Most Recent Note for BABA - 12/14/2017 12:10:09 PM Met resistance at its 50 DMA line ($180.50) when rebounding after a streak of damaging volume-driven losses. Reported earnings +63% on +47% sales revenues for the Sep '17 quarter, its 5th quarterly comparison well above the +25% minimum guideline (C criteria). Owned already by 2,892 top-rated funds. The fact-based investment system's guidelines suggest finding stocks when just beginning to attract institutional interest. Completed its $88 IPO on 9/19/14.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
BGCP - NASDAQ - FINANCIAL SERVICES - Investment Brokerage - Nationa B G C Partners Inc Cl A	$15.05	-0.75 -4.72%	$15.65	$16.97	-11.34%	2,441,092 141.27%	1,728,000
Most Recent Note for BGCP - 12/14/2017 12:11:34 PM Violated its 50 DMA line with today's 3rd consecutive volume-driven loss. Prior mid-day reports cautioned members - "Quarterly earnings comparisons have not been strong and steady above the +25% guideline. This Finance - Investment Bankers/Brokers firm's annual earnings history (A criteria) is not a match with the investment system guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
BLD - NYSE - Bldg-Constr Prds/Misc Topbuild Corp	$67.72	+2.44 3.74%	$67.80	$69.34	-2.34%	145,935 65.15%	224,000
Most Recent Note for BLD - 12/14/2017 12:13:07 PM Found support at its 50 DMA line. Quarterly earnings increases have been above the +25% minimum guideline (C criteria) in the 3 latest comparisons. Reported Sep '17 earnings +32% on just +8% sales revenues. Sub par sales revenues growth and limited annual earnings (A criteria) history is a concern.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CME - NASDAQ - DIVERSIFIED SERVICES - Business/Management Services C M E Group Inc	$150.24	-1.37 -0.90%	$152.60	$155.29	-3.25%	955,032 73.41%	1,301,000
Most Recent Note for CME - 12/14/2017 12:14:00 PM Holding its ground after a streak of volume-driven gains to new all-time highs above its December 2007 high. Earnings increases through the Sep '17 quarter were below the +25% minimum guideline (C criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CUTR - NASDAQ - HEALTH SERVICES - Medical Appliances & Equipment Cutera Inc	$46.68	-1.83 -3.76%	$48.90	$48.95	-4.65%	201,765 86.22%	234,000
Most Recent Note for CUTR - 12/14/2017 12:15:11 PM Perched at a new all-time high after 7 consecutive gains marked by heavy volume. Showed strong sales revenues and earnings increases in the Jun and Sep '17 quarters. FY '16 was its first year of annual earnings, however, to meet the A criteria and match with the fact-based investment system's fundamental guidelines companies should have 3-5 years of strong earnings growth history.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ENFC - NASDAQ - Banks-Southeast Entegra Financial Corp	$29.91	+0.41 1.38%	$30.40	$29.88	0.09%	11,162 79.73%	14,000
Most Recent Note for ENFC - 12/14/2017 12:16:04 PM Wedging to new all-time highs with this week's gains. The 11/09/17 mid-day report noted - "Reported earnings +34% on +14% sales revenues for the Sep '17 quarter. The 2 prior quarterly comparisons had earnings increases below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) growth has been improving after a loss in FY '13."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
FSBW - NASDAQ - Banks-West/Southwest F S Bancorp	$55.94	+0.05 0.09%	$57.36	$58.00	-3.55%	42,335 325.65%	13,000
Most Recent Note for FSBW - 12/14/2017 12:17:34 PM Thinly traded Bank stock is pulling back from its all-time high. Completed a new Public Offering on 9/08/17. Reported Sep '17 earnings -9% on +10% sales revenues. Prior quarterly comparisons were above the +25% minimum guideline (C criteria) and its annual earnings (A criteria) history has been great.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
KMG - NYSE - ENERGY - Independent Oil & Gas K M G Chemicals Inc	$62.43	-0.95 -1.50%	$64.21	$66.16	-5.64%	179,393 86.25%	208,000
Most Recent Note for KMG - 12/14/2017 12:19:18 PM No resistance remains due to overhead supply. Gapped up and rallied into new all-time high territory with considerable volume-driven gains this week. Found support near its 50 DMA line ($54.66) after completing a new Public Offering on 10/20/17. Reported Oct '17 quarterly earnings +73% on +45% sales revenues, marking the 4th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Noted with caution in prior mid-day reports - "Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
KTEC - NASDAQ - MANUFACTURING - Diversified Machinery Key Technology Inc	$20.51	+0.41 2.04%	$20.74	$20.53	-0.10%	12,813 75.37%	17,000
Most Recent Note for KTEC - 12/14/2017 12:19:46 PM Hit new 52-week highs with considerable volume-driven gains this week. Prior mid-day reports repeatedly noted - "Showed improved sales revenues and earnings increases in the Jun and Sep '17 quarters. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NOVT - NASDAQ - Elec-Scientific/Msrng Novanta Inc	$49.90	+0.60 1.22%	$50.20	$55.10	-9.44%	229,701 91.51%	251,000
Most Recent Note for NOVT - 12/14/2017 12:20:18 PM It has not formed a sound base. Reported earnings +55% on +50% sales revenues for the Sep '17 quarter. Prior quarterly earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Sales revenues growth has shown encouraging acceleration, but prior history is not a match with the fact-based investment system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PDEX - NASDAQ - WHOLESALE - Medical Equipment Wholesale Pro Dex Inc	$6.85	-0.20 -2.84%	$7.25	$8.00	-14.38%	12,383 72.84%	17,000
Most Recent Note for PDEX - 12/14/2017 12:20:32 PM Quarterly and annual earnings history (C and A criteria) and sales revenues growth fails to match the fundamental guidelines of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PPC - NASDAQ - FOOD & BEVERAGE - Meat Products Pilgrims Pride Corp	$33.23	-1.78 -5.08%	$34.67	$38.39	-13.44%	662,224 65.31%	1,014,000
Most Recent Note for PPC - 12/14/2017 12:21:41 PM Testing support at its 50 DMA line. Earnings history is not a match with the fact-based investment system's guidelines (C & A criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PRAH - NASDAQ - HEALTH SERVICES - Medical Laboratories & Researc PRA Health Sciences, Inc	$89.01	+1.78 2.04%	$89.81	$88.60	0.46%	408,417 83.35%	490,000
Most Recent Note for PRAH - 12/14/2017 12:29:26 PM Rallying to a new all-time high with its 8th consecutive gain. Recently found support near its 50 DMA line. The 11/09/17 mid-day report noted - "Reported earnings +38% on +28% sales revenues for the Sep '17 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). It completed yet another Secondary Offering on 8/09/17, and prior Secondary Offerings on 3/04/16, 5/04/16, and 11/15/16."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SAFM - NASDAQ - FOOD & BEVERAGE - Meat Products Sanderson Farms Inc	$150.90	-16.74 -9.99%	$160.00	$176.43	-14.47%	830,251 164.73%	504,000
Most Recent Note for SAFM - 12/14/2017 12:31:54 PM Gapped down today and then violated its 50 DMA line ($156.40) with a damaging volume-driven loss. Reported earnings -5% on +16% sales revenues for the Oct '17 quarter. Prior mid-day reports repeatedly noted - "Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SCMP - NASDAQ - Medical-Biomed/Biotech Sucampo Pharmaceuticals	$17.25	+0.75 4.55%	$17.30	$17.70	-2.54%	1,005,842 87.77%	1,146,000
Most Recent Note for SCMP - 12/14/2017 12:32:41 PM Perched at its 52-week high today while adding to an impressive streak of volume-driven gains. Quarterly earnings have been below the +25% minimum guideline (C criteria) in the 3 past quarterly comparisons through Sep '17.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SVA - NASDAQ - DRUGS - Biotechnology Sinovac Biotech Ltd	$8.05	+0.08 1.00%	$8.11	$7.98	0.88%	303,599 137.38%	221,000
Most Recent Note for SVA - 12/14/2017 12:33:02 PM This Chinese developer of vaccines is hovering in tight trading range perched near multi-year highs. Prior mid-day reports cautioned members - "Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
TREE - NASDAQ - Finance-Mrtg&Rel Svc Lendingtree Inc.	$336.80	+11.20 3.44%	$340.05	$326.50	3.15%	181,219 84.68%	214,000
Most Recent Note for TREE - 12/14/2017 12:33:37 PM Hitting another new all-time high with today's gain. Reported Sep '17 earnings +65% on +81% sales revenues, but fundamental concerns remain. Prior mid-day reports cautioned members - "Earnings history is not a match with the fact-based investment system's guidelines (C and A criteria)."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
TWTR - NYSE - INTERNET - Content Twitter Inc	$22.64	+0.98 4.52%	$23.24	$22.48	0.71%	20,534,589 107.84%	19,042,000
Most Recent Note for TWTR - 12/14/2017 12:35:06 PM Hitting a new 52-week high today. Last noted with caution in the 10/27/17 mid-day report - "Reported earnings +11% on -4% sales revenues for the Sep '17 quarter. Quarterly and annual earnings history is not a match with the fact-based investment system's fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
UBFO - NASDAQ - Banks-West/Southwest United Security Bncsh Ca	$10.85	-0.05 -0.46%	$10.95	$11.00	-1.36%	12,475 65.66%	19,000
Most Recent Note for UBFO - 12/14/2017 12:35:25 PM Perched at its all-time high today while adding to an impressive spurt of gains. This thinly traded Bank holding company showed better sales revenues and earnings increases in the Jun and Sep '17 quarters. Prior earnings and sales revenues growth history is not a match with the fact-based investment system's fundamental guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
XOMA - NASDAQ - DRUGS - Biotechnology Xoma Corp	$31.74	-2.09 -6.18%	$33.82	$34.44	-7.84%	161,601 90.28%	179,000
Most Recent Note for XOMA - 12/14/2017 12:36:15 PM Quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.